The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Global Trends in Anaphylaxis Epidemiology and Clinical Implications
Open accessAbstract
The true global scale of anaphylaxis remains elusive, because many episodes occur in the community without presentation to health care facilities, and most regions have not yet developed reliable systems with which to monitor severe allergic events. The most robust data sets currently available are based largely on hospital admissions, which are limited by inherent issues of misdiagnosis, misclassification, and generalizability. Despite this, there is convincing evidence of a global increase in rates of all-cause anaphylaxis, driven largely by medication- and food-related anaphylaxis. There is no evidence of parallel increases in global all-cause anaphylaxis mortality, with surprisingly similar estimates for case-fatality rates at approximately 0.5% to 1% of fatal outcomes for hospitalizations due to anaphylaxis across several regions. Studying regional patterns of anaphylaxis to certain triggers have provided valuable insights into susceptibility and sensitizing events: for example, the link between the mAb cetuximab and allergy to mammalian meat. Likewise, data from published fatality registers can identify potentially modifiable risk factors that can be used to inform clinical practice, such as prevention of delayed epinephrine administration, correct posturing during anaphylaxis, special attention to populations at risk (such as the elderly on multiple medications), and use of venom immunotherapy in individuals at risk of insect-related anaphylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
Muraro, A., Roberts, G., Worm, M., Bilò, M. B., Brockow, K., Fernández Rivas, M., Santos, A. F., Zolkipli, Z. Q., Bellou, A., Beyer, K., et al. (2014) · Allergy · doi:10.1111/all.12437 · Cited by 1,057
AR101 Oral Immunotherapy for Peanut Allergy
The PALISADE Group of Clinical Investigators (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1812856 · Cited by 765
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Allan Bock, S., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.018 · Cited by 748
Self-citationTurner, P. J., Gowland, M. H., Sharma, V., Ierodiakonou, D., Harper, N., Garcez, T., Pumphrey, R., & Boyle, R. J. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.021 · Cited by 693
Self-citation2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
Simons, F. E. R., Ebisawa, M., Sanchez-Borges, M., Thong, B. Y., Worm, M., Tanno, L. K., Lockey, R. F., El-Gamal, Y. M., Brown, S. G., Park, H.-S., et al. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0080-1 · Cited by 594
Fatal Anaphylaxis: Mortality Rate and Risk Factors
Turner, P. J., Jerschow, E., Umasunthar, T., Lin, R., Campbell, D. E., & Boyle, R. J. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.06.031 · Cited by 546
Self-citationAnaphylaxis fatalities and admissions in Australia
Liew, W. K., Williamson, E., & Tang, M. L. K. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.049 · Cited by 453
Fatal anaphylaxis in the United States, 1999-2010: Temporal patterns and demographic associations
Jerschow, E., Lin, R. Y., Scaperotti, M. M., & McGinn, A. P. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.018 · Cited by 403
Postmortem findings after fatal anaphylactic reactions: Table 1
Pumphrey, R. S. H., & Roberts, I. S. D. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.4.273 · Cited by 293
Cited by
World Allergy Organization Anaphylaxis Guidance 2020
Cardona, V., Ansotegui, I. J., Ebisawa, M., El-Gamal, Y., Fernandez Rivas, M., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Sanchez Borges, M., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100472 · Cited by 1,186
Self-citationEuropean Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Kiguchi, T., Yamamoto-Hanada, K., Saito-Abe, M., Sato, M., Irahara, M., Ogita, H., Miyagi, Y., Inuzuka, Y., Toyokuni, K., Nishimura, K., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249649 · Cited by 41
Metadata
- Authors
- Turner, P. J., Campbell, D. E., Motosue, M. S., & Campbell, R. L.
- Venue
- The Journal of Allergy and Clinical Immunology: In Practice
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 8
- Issue
- 4
- Pages
- 1169-1176
- ISSN
- 2213-2198 (ISSN-L)
- OpenAlex
- W2991634674
- Cited by
- 296
- References
- 66
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global Trends in Anaphylaxis Epidemiology and Clinical Implications. https://app.cochat.ai/papers/10.1016/j.jaip.2019.11.027
- The paper
- Turner, P. J., Campbell, D. E., Motosue, M. S., & Campbell, R. L. (2020). Global Trends in Anaphylaxis Epidemiology and Clinical Implications. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2019.11.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.